Inhibitory Effects of Ethyl Acetate Extract of Andrographis paniculata on NF-κB Trans-Activation Activity and LPS-Induced Acute Inflammation in Mice by Chao, Wen-Wan et al.
Hindawi Publishing Corporation
Evidence-Based Complementary and Alternative Medicine
Volume 2011, Article ID 254531, 9 pages
doi:10.1093/ecam/nep120
Original Article
Inhibitory Effects of Ethyl Acetate Extract of Andrographis
paniculata on NF-κB Trans-Activation Activity and LPS-Induced
Acute Inﬂammation in Mice
Wen-Wan Chao,1 Yueh-HsiungKuo,2,3 Shie-LiangHsieh,4 andBi-Fong Lin1
1Department of Biochemical Science and Technology, Institute of Microbiology and Biochemistry, College of Life Science,
National Taiwan University, Taiwan
2Department of Chemistry, National Taiwan University, Taipei, Taiwan
3Tsuzuki Institute for Traditional Medicine, College of Pharmacy, China Medical University, Taichung, Taiwan
4Department and Institute of Microbiology and Immunology, National Yang-Ming University, Taiwan
Correspondence should be addressed to Bi-Fong Lin, bifong@ntu.edu.tw
Received 26 November 2008; Accepted 17 July 2009
Copyright © 2011 Wen-Wan Chao et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
This study was to investigate anti-inﬂammatory eﬀect of Andrographis paniculata (Burm. f.) Nees (Acanthaceae) (AP). The
eﬀects of ethyl acetate (EtOAc) extract from AP on the level of inﬂammatory mediators were examined ﬁrst using nuclear factor
kappa B (NF-κB) driven luciferase assay. The results showed that AP signiﬁcantly inhibited NF-κB luciferase activity and tumor
necrosis factor α (TNF-α), interleukin 6 (IL-6), macrophage inﬂammatory protein-2 (MIP-2) and nitric oxide (NO) secretions
from lipopolysaccharide (LPS)/interferon-γ stimulated Raw264.7 cells. To further evaluate the anti-inﬂammatory eﬀects of AP
in vivo, BALB/c mice were tube-fed with 0.78 (AP1), 1.56 (AP2), 3.12 (AP3) and 6.25 (AP4)mgkg−1 b o d yw e i g h t( B W ) / d a yi n
soybean oil, while the control and PDTC (pyrrolidine dithiocarbamate, an anti-inﬂammatory agent) groups were tube-fed with
soybean oil only. After 1 week of tube-feeding, the PDTC group was injected with 50mgkg−1 B WP D T Ca n d1hl a t e r ,a l lo ft h e
mice were injected with 15mgkg−1 BW LPS. The results showed that the AP1, AP2, AP3 and PDTC groups, but not AP4, had
signiﬁcantly higher survival rate than the control group. Thus, the control, AP1, AP2, AP3 and PDTC groups were repeated for
in vivo parameters. The results showed that the AP and PDTC groups had signiﬁcantly lower TNF-α, IL-12p40, MIP-2 or NO in
serumorperitonealmacrophagesandinﬁltrationofinﬂammatorycellsintothelungofmice.TheAP1groupalsohadsigniﬁcantly
lower MIP-2 mRNA expression in brain. This study suggests that AP can inhibit the production of inﬂammatory mediators and
alleviate acute hazards at its optimal dosages.
1.Introduction
Andrographis paniculata (Burm. F.) Nees (Acanthaceae)
(AP), also known as Chuan-Chin-Lian in Chinese, is
a traditional medicine herb used for the treatment of
infection, inﬂammation, cold, fever, diarrhea and snake-
bite as an antidote [1]. Its active constituents such as
andrographolide, neoandrographolide and 14-deoxy-11,12-
didehydroandrographolide have been studied for anti-
inﬂammatory, anti-cancer and cardiovascular eﬀects [2–
4]. Andrographolide, recognized as the most medicinally
active phytochemical in AP, has been reported to inhibit
lipopolysaccharide(LPS)-inducednitricoxide(NO)produc-
tion through suppression of inducible nitric oxide synthase
(iNOS), and nuclear factor kappa B (NF-κB) activation by
blocking the binding of NF-κB oligonucleotide to nuclear
proteins [5, 6].
Our previous study also indicated that NF-κBd e p e n d e n t
luciferase reporter assay may serve as pre-screen tool to iden-
tify anti-inﬂammatory Chinese medicinal herbs extracted
by hexane, ethyl acetate (EtOAc) or H2O[ 7]. Among
these diﬀerent fractions, the EtOAc extract from AP, one
of those 22 selected traditional Chinese medicine herbs
screened out by suppression of NF-κB luciferase activity,
alsodecreasedNOandPGE2 productioninLPS/interferon-γ
(IFN-γ stimulated macrophage cell line [8]), suggesting that
AP is worth for further in vivo evidence-based research on
anti-inﬂammatory eﬀect.2 Evidence-Based Complementary and Alternative Medicine
In vivo inﬂammatory progresses are mediated by the
involvement of pro-inﬂammatory mediators, including
tumor necrosis factor α (TNF-α), interleukin 6 (IL-6), IL-12,
IFN-γ, NO and macrophage inﬂammatory protein-2 (MIP-
2).Theproperproductionofthesecytokineshelpstheinnate
immune response, but an overproduction results in acute
phase endotoxemia and causes tissue injury, septic shock
and even death [9]. Sepsis is generally considered a systemic
inﬂammatory disorder and a serious clinical problem with
high mortality [10]. Injection of LPS in murine model
induces acute inﬂammation, with increased mRNA levels of
pro-inﬂammatory mediators such as TNF-α,I L - 6 ,I L - 1 β and
MIP-2 in the brain and lung [11, 12].
Hence, the present study was to evaluate the anti-
inﬂammatory eﬀect of the EtOAc extract from AP on in vitro
NF-κB-dependent reporter activity and in vivo LPS-induced
acute inﬂammatory murine model.
2. Methods
2.1. Extraction and Semi-Puriﬁcation of AP. AP was pur-
chased from a licensed Chinese herbal drug store in Taipei
City, and was authenticated by Wei-Chu Li, PhD (Sheng
Chang Pharmaceutical,Co., Ltd, Taiwan) [8]. In total, 10g of
AP was extracted with 300ml of 95% ethanol at 50◦Cf o r3h
twice. The total crude extract was evaporated under vacuum
to yield a residue, and then the residue was suspended in
90% ethanol and successively partitioned with hexane (three
times) and ethyl acetate (three times) to obtain hexane,
EtOAc and water fractions, respectively.
2.2. Transient Transfection and Luciferase Activity Assay. To
investigatetheactivityofNF-κBtrans-activation,weusedthe
p3x-κB luciferase reporter assay system. A reporter plasmid,
3x-κB-tk-luc, has three repeats of the NF-κB site upstream
of a minimal thymidine kinase promoter and a luciferase
reporter gene in pGL2 vector (Promega Corp., Madison,
WI, USA) [13]. The murine macrophage cell line Raw264.7
w e r eg r o wni nD u l b e c c o ’ sM o d i ﬁ e dE a g l eM e d i u m( D M E M )
supplemented with 10% fetal bovine serum (GIBCO, Grand
Island, NY, USA) seeded on 24-well plates (Nunc, Roskilde,
Denmark) at a concentration of 5 × 104 cells/well, then
incubated for overnight. The cells were cotransfected with
0.3μg of the NF-κB-promoted luciferase reporter gene
plasmid pNF-κB-Luc and 0.1μg of Renilla luciferase reporter
plasmid pRL-tk (Promega) for 48h using the ExGen 500
in vitro transfection reagent (Fermentas, Hanover, MD,
USA). After transfection, cells were pre-incubated with AP
EtOAc extract or NF-κB-DNA binding inhibitor Helenalin
(10μM, Calbiochem-Novabiochem Corp., San Diego, USA)
for 1h and then stimulated with LPS (100 ngml−1,S i g m a ,
St Louis, MO, USA) plus IFN-γ (1000Uml−1,S i g m a )
for 8h. Supernatant were collected for cytokines assay.
Luciferase expression was then analyzed using the Dual-
Glo luciferase reporter assay system (Promega) as previously
reported [7]. The cytotoxicity of the AP EtOAc extract (2.5–
20μgml −1), was determined by 3-(4,5-dimethylthiazol-2-
yl]-2,5-diphenylterazolium bromide, MTT, Sigma) assay for
cell viability [8].
2.3. AP Supplement Prior to LPS-Induced Inﬂammation in
Mice. Fifty-four-week-old female BALB/c mice were pur-
chased from the Animal Center of the College of Medicine
at National Taiwan University (Taipei, Taiwan). At age of 8
weeks, mice (20 ± 2g) were divided into six groups: the LPS
group (n = 8, as a control) and the PDTC group (n = 8, as a
positive control) were tube-fed with 100μls o y b e a no i l / d a y ,
while the AP groups (n = 8/group) were tube-fed with
diﬀerent doses of AP EtOAc extract (AP1, 0.78mgkg−1 body
weight (BW); AP2, 1.56mgkg−1 B W ;A P 3 ,3 . 1 2 m g k g −1
BW and AP4, 6.25mgkg−1 BW) in 100μls o y b e a no i l / d a y .
The mice had free access to AIN-76 diet and water and
additionally tube-fed with either soybean oil or AP EtOAc
extract daily. After 1 week of tube feeding, all of the mice
were injected i.p. with 15mgkg−1 BW LPS to induce acute
inﬂammation. Mice in the PDTC group were injected i.p.
with50mgkg−1 BWPDTC(Sigma)1hbeforeLPSchallenge.
This PDTC dose were referred to previous studies showing
anti-inﬂammatory eﬀects in LPS-challenged model [14, 15].
The life spans of these mice that continued on AIN-76 diet
ad lib were recorded.
In the second experiment, the LPS, PDTC, AP1, AP2,
AP3 were repeated to further investigate the inﬂammatory
cytokines production (n = 8/group). A negative control,
the PBS group in this experiment, was injected with PBS
instead of LPS. Sera were collected by retro-orbital bleeding
at 2 and 6h after LPS challenge for cytokine assay. Animal
care and handling conformed to accepted guidelines [16],
and approved by the Institutional Animal Care and Use
Committee NTU (IACUC approval No. 95-072).
2.4. Collection and Culture of Peritoneal Macrophages. To
harvest the female BALB/c mice peritoneal macrophages, all
groups of mice in the second experiment were sacriﬁced
by excessive exposure to anesthetic ether at 6h after LPS
challenge. Peritoneal ﬂuid was collected by i.p. injection
of 9ml of cold Hank’s balanced salt solution (HBSS; Life
Technologies, Paisley, UK). The peritoneal macrophages
were centrifuged and were grown in RPMI-1640 medium
(Hyclone, Logan, UT, USA) supplemented with 2% TCM
(mouse serum replacement, Celox Corp., Hopkins, MN,
USA) and antibiotic-antimycotic (Atlanta Biologicals, Nor-
cross, GA, USA). Cells were inoculated in 48-well plates
(Nunk) at a concentration of 3 × 106 cells/well for 48h and
the culture supernatant was collected and frozen at −70◦C
for the cytokines assay.
2.5. Lung Histology. To evaluate the eﬀects of AP on LPS-
challenged lung inﬂammation, the lung of mice were imme-
diately removed and inﬂated ﬁxed with 10% paraformalde-
hyde. Paraﬃn embedded lungs were sectioned at 3μm
and stained with hematoxylin and eosin for morphologic
analysis.
2.6. Cytokine Measurements. The productions of TNF-α,
IL-6, IL-12p40, MIP-2 and NO in Raw264.7 macrophage
cell supernatants and serum and peritoneal macrophages
of LPS-challenged mice were assayed by commercial ELISAEvidence-Based Complementary and Alternative Medicine 3
kits. IL-6 ELISA kit (PharMingen, San Diego, CA, USA)
and TNF-α, IL-12p40, MIP-2, total NO kits (R&D Systems,
Inc., Minneapolis, MN, USA) were used and the cytokine
concentration was assayed according to the manufacturer’s
cytokine ELISA protocol. Detection sensitivity for NO is
1μM.
2.7. Reverse Transcription Polymerase Chain Reaction for
Cytokine Gene Expression. Detection of MIP-2 mRNA
expression was performed by reverse transcription poly-
merase chain reaction (RT-PCR). Hepatic and brain TNF-
α and iNOS mRNA expression were also measured but
not signiﬁcantly diﬀerent among groups. Liver and brain
tissue samples were collected from animals sacriﬁced at 6h
after LPS challenge. Total RNA was isolated by the TRIzol
method(LifeTechnologies,GIBCO-BRL,Gaithersburg,MD,
USA) according to the manufacturer’s instructions. PCR
primers for MIP-2 and β-actin contained the following
sequences: MIP-2 sense (5 -TGG GTG GGA TGT AGC TAG
TTC C-3 ) and anti-sense (5 -AGT TTG CCT TGA CCC
TGA AGC C-3 )a n dβ-actin sense (5 -ATG GAG AAA
ATC TGG CAC CA-3 ) and anti-sense (5 -AGT CCA TCA
CGA TGC CAG TG-3 ). Equal amounts of RNA (1μg)
were reverse-transcribed into cDNA using oligo (dT) 15
primers, 10μl reaction mixture which containing 1μld N T P
mixture (10mM), 0.25μl RNase inhibitor (Promega) using
M-MLV reverse transcriptase (Promega), then ampliﬁed
using rTaq DNA polymerase (Takara, Japan) in the presence
of a sense/antisense primer pair speciﬁc for the coding
region of the mouse cDNA sequence. The PCR conditions
were as follows: 94◦C, 1min; 55◦C, 1min; 72◦C, 1min for
30 cycles. The ampliﬁed PCR products were subjected to
electrophoresis at 100V through 1.5% agarose gel for about
30 min. Photographs and scans were analyzed with the
BioSpectrum imaging system (UVP, Cambridge, UK).
2.8.StatisticalAnalysis. Thedataareexpressedasthemean ±
standard deviation (SD) or mean ± standard error of mean
(SEM). The signiﬁcant diﬀerence compared with the control
group was statistically by the Student’s t-test using the SAS
software program (SAS/STATA version 8.0; SAS Institute,
Cary, NC, USA). Statistical comparison between diﬀerent
survival curves was analyzed by Cox’s proportional hazards
regression test (STATA version 9.0; Stata Corp., TX, USA).
The correlation was analyzed by simple correlation of the
SAS program. Statistical signiﬁcance is expressed as P < .05.
3. Results
3.1. AP EtOAc Extract Suppresses NF-κBT r a n s c r i p t i o n a l
Activity and Pro-Inﬂammatory Mediators Production in
LPS/IFN-γ Activated Macrophages. Activation of Raw264.7
m a c r o p h a g e sw i t hL P S+I F N - γ resulted in a signiﬁcant
increase in NF-κB trans-activation activity. No cytotoxicity
of AP EtOAc extract up to 20μgml −1 was conﬁrmed by cell
viability (data not shown). To test whether AP EtOAc extract
pretreatment may involve NF-κB activation, we performed
a reporter gene assay with 3x-κB-tk-luciferase transfected
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Figure 1: Eﬀect of the EtOAc extract of AP on NF-κBd e p e n d e n t
luciferase reporter activity in Raw264.7 cells activated by LPS/IFN-
γ (L/I). Raw264.7 macrophages transient transfected with a NF-
κB reporter plasmid were pretreated with 2.5–20μgml −1 of AP
EtOAc extract or helenalin (NF-κB inhibitor, 10μM) for 1h and
then stimulated with LPS 100 ngml−1/IFN-γ 1000Uml−1 for 8h.
The activity of NF-κB was estimated by the Dual-Glo Luciferase
reporter assay. The data are expressed as the mean ± SD from
three independent experiments. (Asterisk indicates the signiﬁcant
as compared with the control group (L/I), P < .05, the Student’s t-
test).
into Raw264.7 macrophages (Figure 1). Addition of NF-
κB binding inhibitor, Helenalin, thoroughly suppressed
reporteractivity.APEtOAcextractpretreatmentsigniﬁcantly
decreased LPS/IFN-γ activated NF-κB luciferase activity in a
dose dependent manner (P < .05).
The levels of TNF-α, IL-6, MIP-2, IL-12p40 and NO
in LPS/IFN-γ-stimulated Raw264.7 macrophages cell super-
natants were also measured (Table 1). Level of IL-12p40
was undetectable in our study (data not shown). The
pretreatment with AP EtOAc extract signiﬁcantly decreased
TNF-α, IL-6, MIP-2 and NO productions in LPS/IFN-γ-
stimulated Raw264.7 macrophages compared with LPS/IFN-
γ treatment only. There was a signiﬁcant correlation between
NF-κBluciferaseactivityandMIP-2level(r =0.85,P <.001).
3.2. Low Doses of AP EtOAc Extract Signiﬁcantly Improved
Survival of LPS-Challenged Mice. To investigate whether
suppression of in vitro pro-inﬂammatory cytokines produc-
tion may beneﬁt survival of LPS-challenged mice, the life
spans were recorded (Figure 2) .T h es u r v i v a lr a t ei nt h e
positive control PDTC group (72%) was signiﬁcantly higher
than that in the control LPS group (31%, P < .01). The
similar survival rate in the AP1, AP2 and AP3 groups (64, 63
and64%,resp.)werealsosigniﬁcantlyhigherthanthatofthe
LPS group (31%) according to the Cox proportion hazards
regression test. Overall, the AP4 group had low survival rate
(18%).4 Evidence-Based Complementary and Alternative Medicine
Table 1: Eﬀects of AP EtOAc extract on pro-inﬂammatory cytokines production from LPS/IFN-γ stimulated Raw264.7 macrophage cells.
Raw264.7 macrophage cells
Treatment TNF-α (pgml−1)I L - 6 ( p g m l −1) MIP-2 (ngml−1)N O ( μM)
Medium only n.d. n.d. n.d. 1.24 ± 0.25
LPS/IFN-γ (L/I) 717 ± 218 410 ± 95 1.48 ± 0.48 6.95 ± 1.21
L/I + Helenalin n.d. n.d. n.d. 2.62 ± 0.62∗
L/I + AP 2.5 667 ± 208 282 ± 98∗ 1.49 ± 0.72 3.29 ± 0.88∗
L/I + AP 5 509 ± 185 275 ± 65∗ 1.39 ± 0.53 3.08 ± 0.80∗
L/I + AP 10 388 ± 115∗ 100 ± 40∗ 1.16 ± 0.48∗ 3.03 ± 0.73∗
L/I + AP 20 348 ± 62∗ 50 ± 10∗ 0.35 ± 0.05∗ 2.87 ± 0.73∗
The data are expressed as the mean ± SD from three independent experiments. The signiﬁcant diﬀerence compared with the control group was statistically
by the Student’s t-test (signiﬁcant as compared with L/I alone, P < .05). Raw264.7 macrophages transient transfection with a NF-κBr e p o r t e rp l a s m i dw e r e
pretreated with 2.5–20μgml −1 of AP EtOAc extract or helenalin (NF-κB inhibitor, 10μM) for 1h and then stimulated with L/I for 8h. Supernatant were
collected and analyses. n.d.: not detectable.
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Figure 2: Eﬀects of EtOAc extract of AP on survival rate of
mice treated with LPS endotoxin. The mice were divided into the
following groups: the PBS, LPS and PDTC groups and the AP
1, 2, 3, 4 groups (tube-feeding 0.78, 1.56, 3.12 and 6.25mgkg−1
BW AP EtOAc extract in 100μl soybean oil/day, resp.). After 1-
week tube-feeding of AP EtOAc extract, all mice were i.p. injected
with 15mgkg−1 BW LPS to induce acute inﬂammation. Mice in
the PDTC group were i.p. injected with 50mgkg−1 BW PDTC 1h
beforeLPSadministration.Statisticalcomparisonbetweendiﬀerent
survival curves was analyzed by Cox’s proportional hazards regres-
sion test. Statistical analysis was performed using the Student’s t-
test for multiple comparisons (Asterisk indicates the signiﬁcant as
compared with LPS alone, P < .05, P < .01).
3.3. Suppression of TNF-α, IL-6, IL-12p40, MIP-2 and NO
Levels in Serum and Peritoneal Exudates Macrophages from
LPS-Challenged Mice Pretreated with AP EtOAc Extract. To
investigate the in vivo anti-inﬂammatory eﬀect of AP EtOAc
extract, levels of pro-inﬂammatory cytokines in serum were
determinedat2and6hafterLPSchallengeinmice(Table 2).
Our data showed that mice injected with LPS had marked
increase of serum TNF-α, IL-6, IL-12p40, MIP-2 and NO,
while mice in the AP and PDTC groups showed signiﬁcantly
lower serum TNF-α levels at 2h after LPS challenge, com-
pared with the LPS group. The PDTC and AP2 groups also
had signiﬁcantly lower TNF-α levels in serum and peritoneal
m a c r o p h a g e sa t6ha f t e rL P Sc h a l l e n g e .I L - 6l e v e l si ns e r u m
and peritoneal macrophages did not signiﬁcantly decrease in
AP EtOAc extract groups as compared with LPS group at 2
and 6h after LPS injection, which may be due to individual
variations.
With regard to IL-12p40, a subunit of the heterodimeric
cytokine, LPS challenge induced an increase in its level
in serum, which was decreased by PDTC and AP espe-
cially signiﬁcantly after 2h challenge. AP2 group also had
signiﬁcantly lower IL-12p40 production from peritoneal
macrophages compared to the LPS group.
Serum MIP-2 levels rose at 2h and dropped at 6h
after LPS challenge and were suppressed by PDTC and
AP, signiﬁcantly in the PDTC and AP1 groups at 2h
after challenge (Table 2). The PDTC and AP2 groups also
had signiﬁcantly lower MIP-2 production from peritoneal
macrophages.
Serum levels of NO was detectable only at 6h after LPS
challenge, and was signiﬁcantly lower in the AP1 and AP2
groups compared with the LPS group. The NO production
by peritoneal macrophages was signiﬁcantly suppressed by
PDTC, and by AP supplementation in a dose-dependent
manner.
3.4. Inhibition of MIP-2 mRNA Expression in Brain by AP
EtOAc Extract. To investigate whether AP aﬀect mRNA
expression, the mRNA expression of MIP-2, TNF-α and
iNOS in liver and brain at 6h after LPS challenge was
measured. Though TNF-α, iNOS and hepatic MIP-2, mRNA
expression were not found signiﬁcantly aﬀe c t e db yP D T Co r
AP (data not shown), MIP-2 mRNA in brain was suppressed
by PDTC and AP, especially signiﬁcantly in the AP1 group
compared with the LPS group (Figure 3).
3.5. AP EtOAc Extract on Inﬂammatory Cell Inﬁltration. As
illustrated in Figure 4, the lung of mice injected with LPS
showed marked inﬂammation characterized by inﬁltration
of inﬂammatory cells into the alveolar space, a thickening ofEvidence-Based Complementary and Alternative Medicine 5
Table 2: Eﬀects of AP EtOAc extract on levels of pro-inﬂammatory mediators in serum and peritoneal exudates macrophages at 6h in
BALB/c mice treated with LPS.
Groups TNF-α (pgml−1)I L - 6 ( n g m l −1) IL-12p40 (ngml−1) MIP-2 (ngml−1)N O ( μM)
Serum
2h
PBS n.d. n.d. n.d. n.d. n.d.
LPS 2325 ± 504 167 ± 14.2 11.5 ± 2.38 140.6 ± 5.3 n.d.
PDTC 737 ± 174∗ 161 ± 15.8 3.57 ± 0.71∗ 64.1 ± 3.0∗ n.d.
AP1 1175 ± 113∗ 200 ± 52.0 10.7 ± 1.03 73.8 ± 3.5∗ n.d.
AP2 1150 ± 96∗ 136 ± 11.7 9.84 ± 1.16∗ 86.8 ± 4.7 n.d.
AP3 2647 ± 1292 145 ± 11.5 2.01 ± 0.35∗ 110.3 ± 8.0 n.d.
6h
PBS n.d. n.d. n.d. n.d. n.d.
LPS 660 ± 62 295 ± 38.3 23.7 ± 2.66 34.4 ± 3.1 234 ± 34.8
PDTC 403 ± 38∗ 148 ± 30.6 11.7 ± 0.80∗ 24.0 ± 2.6 192 ± 33.8
AP1 483 ± 31 110 ± 30.6 24.1 ± 2.30 15.1 ± 5.5 85 ± 5.30∗
AP2 400 ± 32∗ 231 ± 35.3 19.3 ± 1.97 28.7 ± 2.9 101 ± 17.5∗
AP3 434 ± 55 333 ± 51.5 18.7 ± 2.08 27.7 ± 5.6 310 ± 34.4
Peritoneal macrophages
6h
PBS n.d. n.d. n.d. n.d. n.d.
LPS 158 ± 13 37.9 ± 7.3 40.4 ± 6.7 14.4 ± 1.0 53.3 ± 1.7
PDTC 89 ± 6.1∗ 30.6 ± 6.9 31.2 ± 5.1 6.7 ± 0.8∗ 22.7 ± 4.7∗
AP1 102 ± 12 53.5 ± 7.5 40.0 ± 4.0 13.6 ± 1.3 39.7 ± 4.0∗
AP2 89 ± 6.1∗ 41.4 ± 8.9 24.8 ± 2.7∗ 6.3 ± 0.5∗ 33.4 ± 4.6∗
AP3 238 ± 53 17.3 ± 3.0 30.2 ± 4.5 7.6 ± 1.0 24.5 ± 4.3∗
The mice were divided into the following treatment groups: LPS group; PDTC group; AP1 group, a dose of 0.78mgkg−1 BW AP; AP2 group, a dose of
1.56mgkg−1 BW AP; AP3 group, a dose of 3.12mgkg−1 BW AP. Treatments were administrated orally 7 days before LPS challenge (15mgkg−1, i.p.). Data
are expressed as mean ± SD of eight mice. Statistical analysis was performed using the Student’s t-test (signiﬁcant as compared with LPS alone, ∗P < .05).
n.d.: not detectable.
the alveolocapillary membrane, and the presence of alveolar
hemorrhage (Figure 4(b)) when compared with those of
miceinjectedwithPBS(Figure 4(a)).Incontrast,histological
damage was less pronounced in PDTC or AP-treated mice
(Figures 4(c)–4(e)).
4. Discussion
To investigate the potential of bioactive chemicals con-
tained in natural health products as eﬀective drug therapy,
methods involving gene expression analysis, cell membrane
chromatography or trans-activated reporter gene assay, have
been developed and proposed as rapid throughput screening
systems [8, 17–19]. Our previous study on pre-screening
of 22 commonly used Chinese herbs by NF-κB-dependent
activity implies that AP EtOAc extract exerts an anti-
inﬂammatory eﬀect [7]. In this study, AP EtOAc extract
was conﬁrmed not only to inhibit NF-κBa c t i v a t i o nd o s e -
dependently(Figure 1),butalsoTNF-α,IL -6,MIP -2andNO
production in LPS/IFN-γ stimulated Raw264.7 macrophages
(Table 1). NF-κB activation is a central event leading to the
activation of complex cytokine and inﬂammatory mediator
network in septic shock and inﬂammation. The activation
of NF-κB results in the expression of genes encoding
inﬂammationmediatorssuchasTNF-α,IL-6,MIP -2andNO
[20], which were suppressed by PDTC and AP in this study.
TNF-α is the cytokine as the target for development
of new medications development for disease involving
inﬂammation, such as rheumatoid arthritis. Inhibition of
elevated TNF-α induced by LPS has been a common practice
for evaluation of anti-inﬂammatory eﬀectof drug candidates
[21, 22]. Our results showed lower production of TNF-
α not only in LPS-stimulated Raw264.7 cells pretreated
by AP but also in serum and from activated peritoneal
macrophagesofLPS-challengedmicesupplementedwithAP,
conﬁrming TNF-α as a target in anti-inﬂammatory strategy.
IL-6 is also an important mediator of inﬂammation. The
secretion of IL-6 by activated Raw264.7 cells was the most
signiﬁcantly inhibited among the cytokines measured in this
study. However, no signiﬁcance eﬀect was observed in LPS-
challenged mice. It may due to the eﬃcacy of dosages applied
in vivo or diﬀerent experimental animal model of sepsis used
[23].
Another cytokine, IL-12p40, was recently shown that
its absence alleviated the chronic phase of arthritis and
reduced iNOS levels, suggesting that IL-12p40 plays a critical
role in late phase of inﬂammation [24]. In this study,
activated Raw264.7 cells produced minimal IL-12p40, while6 Evidence-Based Complementary and Alternative Medicine
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Figure 3: Eﬀects of EtOAc extract on endotoxin induced MIP-2
mRNA expression in brain of BALB/c mice. The mice were divided
into the following groups: the PBS, LPS and PDTC groups and
the AP 1, 2, 3 groups (tube-feeding 0.78, 1.56 and 3.12mgkg−1
BW AP EtOAc extract in 100μl soybean oil/day, resp.). After 1-
week tube-feeding of AP EtOAc extract, all mice were i.p. injected
with 15mgkg−1 BW LPS to induce acute inﬂammation. Mice in
the PDTC group were i.p. injected with 50mgkg−1 PDTC 1h
before LPS administration. Results of MIP-2/β-actin mRNA ratio
are expressed as mean ± SEM (n = 8). Statistical analysis was
performedusingStudent’st-testformultiplecomparisons(Asterisk
indicates the signiﬁcant as compared with LPS alone, P < .05).
LPS challenge to mice induced its production in serum and
peritoneal cells and was suppressed by PDTC and AP. NO
is an important mediator in both acute and chronic inﬂam-
mation. The inﬂammatory responses are largely controlled
through regulation of NF-κB[ 6]. The signiﬁcant decrease of
NO production by both Raw264.7 cells and LPS-challenged
mice conﬁrmed our previous report of the association of NO
production and NF-κB-dependent reporter activity [8].
Although the suppression did not necessarily reach
statistically signiﬁcance in all the parameters measured in
this study, the survival rate in murine endotoxin shock, a
director indicator for anti-inﬂammation, suggested a link of
testsamplesinvitropotencywithitsinvivoactivities.Further
analysis of the correlation between life span and serum
cytokine levels indicated that life span negatively correlated
with serum TNF-α and MIP-2 levels (r = −0.60, P < .001
for TNF-α; r = −0.56, P = .03 for MIP-2) at 2h after LPS-
challenge, and serum NO levels (r = −0.58, P = .02) at 6h
after LPS-challenge. This implies that suppression of TNF-
α and MIP-2 in the early stage of acute-inﬂammation may
prolong the life of mice suﬀering from endotoxic shock, and
inhibition of NO production in the late stage still beneﬁt
animal survival.
It has been shown that MIP-2 mRNA expression can
be induced tissue-speciﬁcally in lung, brain, kidney and
heart in endotoxemia mice [25]. Brain plays a key role
in modulating the immune response, and inappropriate
bilateral interplay between the central nervous and immune
systemsmayhavedetrimentalconsequencesduringinfection
and inﬂammatory processes. Thus, brain MIP-2 mRNA
were also detected in our study (Figure 3). MIP-2 in mouse
hypothalamus induces neutrophil inﬁltration and permeabi-
lizes the blood-brain barrier thus permitting the entry of
leukocytes across the parenchyma [26], suggesting that MIP-
2 play an important role in neutrophil accumulation in brain
tissues [27].
Our analysis of relationship between NF-κBl u c i f e r a s e
activityandtheseinﬂammatorymediatorsobtainedasigniﬁ-
cantcorrelationbetweenNF-κBluciferaseactivityandMIP-2
level in activated Raw264.7 cells. MIP-2, a critical chemokine
for neutrophils recruitment, is secreted by macrophage and
epithelial cells in response to inﬂammatory stimuli, such
as LPS [28]. Its expression induced by LPS is dependent
on NF-κBa c t i v a t i o n[ 29], and important for neutrophil
accumulation in inﬂammatory response in lung [30]. Our in
vivostudyalsodemonstratedthatLPS-challengedmiceinthe
AP1, AP2 and PDTC groups that had lower MIP-2 in serum
orproducedfromperitonealmacrophage,mRNAexpression
in brain, and also less inﬂammatory cell inﬁltration in lung
(Figure 4). These results are in accordance with the higher
survival rate in these groups, suggesting that suppression of
MIP-2 production is an important indicator for alleviation
of inﬂammatory process.
LPS released during bacterial infections induce the
expression of pro-inﬂammatory cytokines. Systemic inﬂam-
mation leads to inﬂammatory responses in the brain.
The secretion of cytokines and inﬂammatory mediators
induce sickness behavior characterized by fever, lethargy,
hypophagia, anxiety and depression, and so forth, [31]. In
traditional Chinese medicine, AP is used to get rid of the
body heat, for example, fevers and acute infections and to
dispel toxins from the body. AP was shown to inhibit the
pro-inﬂammatory chemokine RANTES secretion by human
bronchial epithelial cells infected with inﬂuenza A virus
H1N1 [32]. Our results demonstrate that AP can also inhibit
MIP-2 mRNA expression. Mechanism of action of MIP-
2 on inﬂammation in brain is less documented compared
with those of cytokines and chemokines, such as TNF-α,
IL-1β, MCP-1 and MIP-1, though they all increase in both
the periphery and in the brain when LPS is administered
peripherally [33, 34]. The identiﬁcation of bioactive com-
pounds in AP EtOAc extract and its signiﬁcance of MIP-
2 suppression on inﬂammation are worthy of investigation.
The isolation and identiﬁcation of anti-inﬂammatory eﬀect
of these compounds are undergoing in our laboratory. By
bioactivity-guided chromatographic fractionation, the ratio
of the bioactive compounds is 23% of the AP EtOAc extract,
with major compounds such as andrographolide (12%), 14-
deoxy-11,12-didehydroandrographolide (6.8%) and ergos-
terol peroxide (3.2%) that exerting signiﬁcant inhibition of
NF-κB trans-activation.
However, the AP 4 group with higher dose of AP EtOAc
extract showed lower survival rate (Figure 2). Although
further studies are required to clarify the reasons, it isEvidence-Based Complementary and Alternative Medicine 7
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Figure 4: Morphological changes in mouse lung sections on LPS induction of sepsis with/without treatment with EtOAc extract of AP.
Histopathologic analysis was performed on hematoxylin and eosin (H. E.) stained sections of lung at 6h after LPS administration. (a) PBS
group was received an i.p. injection of PBS buﬀer; (b) LPS group, received an i.p. injection of 15mgkg−1 BW LPS severe lung edema and
inﬂammatory cells inﬁltration (arrow) were observed in this group; (c) PDTC + LPS group, received an i.p. injection of 50mgkg−1 BW
PDTC 1h before LPS administration; (d) AP 1 group, was given an oral dose of 0.78mgkg−1 BW AP; (e) AP 2 group, was given an oral dose
of 1.56mgkg−1 B WA P ;( f)A P3g r o u p ,w a sg i v e na no r a ld o s eo f3 . 1 2m gk g −1 BW AP. (magniﬁcation 400x).
known that traditional Chinese medicine have their optimal
eﬀective dosage and overdose may cause side-eﬀect or
toxicity. Studies of acute toxicity in mice reported a lethal
dose (LD50) of some components of AP, such as diterpene
lactones, deoxyandrographolide, neoandrographolide, dehy-
droandrographolide and andrographolide [35], suggesting
that traditional herb medicine has its optimal and eﬀective
dosages [36].
In conclusion, pretreatment of AP EtOAc extract
that inhibit NF-κB trans-activation activity and pro-
inﬂammatory cytokines in vitro, protects mice against sub-
lethal endotoxic shock. Pro-inﬂammatory cytokines such as
TNF-α, IL-12p40, MIP-2 and NO in serum and activated
peritoneal macrophage are signiﬁcantly inhibited, and thus
the survival rates of LPS-challenged mice are improved by
AP EtOAc extract at the optimal dosages (Figure 5).8 Evidence-Based Complementary and Alternative Medicine
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Figure 5: In vitro and in vivo biological actions of ethyl acetate extract of AP as an anti-inﬂammatory traditional medicine herb. Prohibition
sign indicate the inhibitory eﬀect of ethyl acetate extract of AP.
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